https://orcid.org/0000-0003-1007-3820
References
- Bohan A, Peter JB. Polymyositis and dermatomyositis (first of two parts). N Engl J Med. 1975;292(7):344–347.
- Bohan A, Peter JB. Polymyositis and dermatomyositis (second of two parts). N Engl J Med. 1975;292(8):403–407.
- Cherin P. Inflammatory myopathies. Acta Clin Belg. 2004;59(5):290–299.
- Meyer A, Meyer N, Schaeffer M, et al. Incidence and prevalence of inflammatory myopathies: a systematic review. Rheumatology. 2015;54(1):50–63.
- Satoh M, Tanaka S, Ceribelli A, et al. A comprehensive overview on myositis-specific antibodies: new and old biomarkers in idiopathic inflammatory myopathy. Clin Rev Allergy Immunol. 2017;52(1):1–19.
- Rider LG, Shah M, Mamyrova G, et al. The myositis autoantibody phenotypes of the juvenile idiopathic inflammatory myopathies. Medicine (Baltimore). 2013;92(4):223–243.
- Bosch X, Poch E, Grau JM. Rhabdomyolysis and acute kidney injury. N Engl J Med. 2009;361(1):62–72.
- Fraser DD, Frank JA, Dalakas M, et al. Magnetic resonance imaging in the idiopathic inflammatory myopathies. J Rheumatol. 1991;18(11):1693–1700.
- Yildiz H, Roelants V, Hainaut P. Statin-induced rhabdomyolysis mimicking polymyositis on (18)F-FDG PET imaging. Acta Clin Belg. 2015;70(2):151–152.
- Sheehy N, Israel DA. Findings on (18)FDG-PET imaging in statin-induced rhabdomyolysis. Clin Radiol. 2007;62(10):1012–1014.
- Inoue M, Tanboon J, Hirakawa S, et al. Association of dermatomyositis sine dermatitis with anti-nuclear matrix protein 2 autoantibodies. JAMA Neurol. 2020;77(7):872–877.
- Cucchiari D, Angelini C. Renal involvement in idiopathic inflammatory myopathies. Clin Rev Allergy Immunol. 2016. DOI:10.1007/s12016-015-8524-5
- Aggarwal R, Dhillon N, Fertig N, et al. A negative antinuclear antibody does not indicate autoantibody negativity in myositis: role of anticytoplasmic antibody as a screening test for antisynthetase syndrome. J Rheumatol. 2016;44(2):223–232.
- Espinosa-Ortega F, Holmqvist M, Alexanderson H, et al. Comparison of autoantibody specificities tested by a line blot assay and immunoprecipitation-based algorithm in patients with idiopathic inflammatory myopathies. Ann Rheum Dis. 2019;78(6):858–860.
- Cavazzana I, Fredi M, Ceribelli A, et al. Testing for myositis specific autoantibodies: comparison between line blot and immunoprecipitation assays in 57 myositis sera. J Immunol Methods. 2016;433:1–5.
- Piette Y, De Sloovere M, Vandendriessche S, et al. Pitfalls in the detection of myositis specific antibodies by lineblot in clinically suspected idiopathic inflammatory myopathy. Clin Exp Rheumatol. 2020;38(2):212–219.
- Lampa J, Nennesmo I, Einarsdottir H, et al. MRI guided muscle biopsy confirmed polymyositis diagnosis in a patient with interstitial lung disease. Ann Rheum Dis. 2001;60(4):423–426.
- Lundberg IE, Tjärnlund A, Bottai M, et al. EULAR/ACR Classification criteria for adult and juvenile idiopathic inflammatory myopathies and their major subgroups HHS public access. Ann Rheum Dis. 2017;76(12):1955–1964.
- Damoiseaux J, Vulsteke J-B, Tseng C-W, et al. Autoantibodies in idiopathic inflammatory myopathies: clinical associations and laboratory evaluation by mono- and multispecific immunoassays. Autoimmun Rev. 2019;18(3):293–305.